The Average Direct Costs Associated with Parkinson's Total $21,000 Annually

Healthcare services account for nearly half of the expenses tied to Parkinson’s disease, but the financial impact extends far beyond medical costs. Loss of productivity and the financial strain on patients and their families also contribute significantly, as revealed by a comprehensive study. The study found that the average annual cost per Parkinson’s patient is about €21,000 (roughly $23,200), though this figure can vary greatly depending on the patient's location and the severity of their condition. Researchers noted that factors like reduced employment, reliance on government benefits, the need for informal care, and the costs of medication, nursing homes, and hospital stays comprise the bulk of the expenses linked to Parkinson’s. This analysis, titled “Systematic Review of the Cost of Illness of Parkinson’s Disease from a Societal Perspective,” was published in Movement Disorders. It highlights the extensive effects Parkinson’s has on patients’ lives, including a reduction in their quality of life, work capacity, and ability to carry out everyday tasks. Moreover, these challenges don’t just affect patients but also place heavy demands on their families and caregivers. The healthcare system itself bears a considerable portion of the burden as well. To fully understand Parkinson’s financial impact, cost-of-illness studies examine and quantify all related expenses. However, most existing research has primarily focused on healthcare costs, which fails to capture the broader economic toll the disease takes on society. To address this, researchers in the Netherlands analyzed multiple studies to assess the broader societal costs of Parkinson’s, including healthcare, informal care, travel, and lost productivity. The researchers reviewed 17 studies conducted from 2010 to 2023, drawing from countries like the U.S., Australia, Brazil, and several in Europe and Asia. The majority of these studies involved 100-500 participants, with follow-up periods ranging from three months to 11 years, though most lasted about a year. Most studies used questionnaires to evaluate economic impact, supplemented by chart reviews, patient interviews, or insurance data. According to their findings, the average cost per Parkinson’s patient per year is around €21,000, translating to a global cost of about €250 billion (roughly $277 billion) annually. Costs were highest in North America, where they were 3.6 times greater than in Asia. The disease's progression also played a major role in increasing expenses: people with advanced Parkinson’s faced costs 4.4 times higher than those in the early stages of the disease, largely due to the need for more intensive healthcare services such as nursing homes and hospital care, as well as a greater reliance on informal care. Healthcare costs alone accounted for 46.1% of the total expenses linked to Parkinson’s, making it the largest contributor. Productivity loss came in second at 37.4%, followed by the out-of-pocket costs borne by patients and their families, which made up 16.4% of the total expenses. These percentages varied across regions, with healthcare costs being the largest factor in North America and Western Europe, while lost productivity had a bigger impact in Asia. The study concluded that reduced employment, government disability benefits, informal care, medication, and nursing homes were among the most significant contributors to the overall costs in all regions. Given the significant financial burden of Parkinson’s disease, the researchers recommended developing a standardized guideline for measuring the cost of illness, to ensure more consistent and comprehensive data across future studies.